董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Roberto Santa Maria Ros | 男 | Independent Director | 69 | 21.00万美元 | 未持股 | 2021-03-18 |
| Stephen L. Ondra | 男 | Independent Director | 63 | 8.42万美元 | 未持股 | 2021-03-18 |
| Gail B. Marcus | 女 | Independent Director | 64 | 20.20万美元 | 未持股 | 2021-03-18 |
| Luis A. Clavell Rodriguez | 男 | Director | 69 | 31.00万美元 | 未持股 | 2021-03-18 |
| Manuel Figueroa Collazo | 男 | Independent Director | 69 | 19.00万美元 | 未持股 | 2021-03-18 |
| Roberto Garcia Rodriguez | 男 | Director, President and Chief Executive Officer | 57 | 373.02万美元 | 未持股 | 2021-03-18 |
| Cari M. Dominguez | 女 | Independent Director | 72 | 21.50万美元 | 未持股 | 2021-03-18 |
| David H. Chafey, Jr. | 男 | Independent Director | 67 | 20.20万美元 | 未持股 | 2021-03-18 |
| Joseph A. Frick | 男 | Independent Director | 68 | 20.50万美元 | 未持股 | 2021-03-18 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Madeline Hernandez Urquiza | 女 | Executive Vice President and Chief Operating Officer, President of Triple-S Salud, Inc. and President of Triple-S Advantage, Inc | 57 | 191.18万美元 | 未持股 | 2021-03-18 |
| Jose. Novoa Loyola | 男 | Chief Medical Officer of Triple-S Salud, Inc. | 56 | 111.00万美元 | 未持股 | 2021-03-18 |
| Jose M. Del Amo Mojica | 男 | President of Triple-S Propiedad, Inc. | 54 | 未披露 | 未持股 | 2021-03-18 |
| Ilia S. Rodriguez Torres | 女 | Chief Human Resources Officer | 51 | 未披露 | 未持股 | 2021-03-18 |
| Ivelisse M. Fernandez Cruz | 女 | Chief Marketing and Communications Officer | 49 | 未披露 | 未持股 | 2021-03-18 |
| Pedro Aponte Gil De Lamadrid | 男 | Chief Information Officer of Triple-S Salud, Inc. | 51 | 未披露 | 未持股 | 2021-03-18 |
| Juan R. Serrano | 男 | Executive Vice President and Chief Strategy and Healthcare Delivery Officer | 57 | 未披露 | 未持股 | 2021-03-18 |
| Arturo Carrion Crespo | -- | President of Triple-S Vida, Inc. | 63 | 102.66万美元 | 未持股 | 2021-03-18 |
| Juan J. Roman Jimenez | 男 | Executive Vice President and Chief Financial Officer | 55 | 201.13万美元 | 未持股 | 2021-03-18 |
| Roberto Garcia Rodriguez | 男 | Director, President and Chief Executive Officer | 57 | 373.02万美元 | 未持股 | 2021-03-18 |
| Carlos L. Rodriguez Ramos | 男 | Chief Legal Counsel and Corporate Secretary | 42 | 未披露 | 未持股 | 2021-03-18 |
董事简历
中英对照 | 中文 | 英文- Roberto Santa Maria Ros
-
Roberto Santa Maria Ros，他曾是PwC的波多黎各圣胡安办公室的管理合伙人直到2012年退休。他于1973年加入PwC，他于I9SS年被任命为合伙人。2004年他被任命为合伙人管理PwC的审计实践部门以及圣胡安办公室的管理合伙。此前从2003年到2012年，他担任圣胡安办公室的管理合伙。他目前担任the Angel Ramos Foundation的的董事会成员和the Pueito Rico chapter of United Way Worldwide的董事会成员。
Roberto Santa Maria Ros is a retired audit partner of Pricewaterhouse Coopers, LLC PwC. He joined the Audit Practice of PwC in 1973 and was admitted to the partnership in 1988. From 2004 until his retirement in 2012 Mr. Santa María was partner-in-charge of PwC’s audit practice division as well as managing partner of the San Juan Office. While at PwC, he served several SEC registered clients as well as private companies in several industries. He currently serves as President and member of the board of the Angel Ramos Foundation, the largest private foundation in Puerto Rico. Mr. Santa María is a NACD Board Leadership Fellow. - Roberto Santa Maria Ros，他曾是PwC的波多黎各圣胡安办公室的管理合伙人直到2012年退休。他于1973年加入PwC，他于I9SS年被任命为合伙人。2004年他被任命为合伙人管理PwC的审计实践部门以及圣胡安办公室的管理合伙。此前从2003年到2012年，他担任圣胡安办公室的管理合伙。他目前担任the Angel Ramos Foundation的的董事会成员和the Pueito Rico chapter of United Way Worldwide的董事会成员。
- Roberto Santa Maria Ros is a retired audit partner of Pricewaterhouse Coopers, LLC PwC. He joined the Audit Practice of PwC in 1973 and was admitted to the partnership in 1988. From 2004 until his retirement in 2012 Mr. Santa María was partner-in-charge of PwC’s audit practice division as well as managing partner of the San Juan Office. While at PwC, he served several SEC registered clients as well as private companies in several industries. He currently serves as President and member of the board of the Angel Ramos Foundation, the largest private foundation in Puerto Rico. Mr. Santa María is a NACD Board Leadership Fellow.
- Stephen L. Ondra
-
StephenL.Ondra目前是North Star梦百合Consulting，LLC的首席执行官，该公司由他于2017年创立。此前，他曾担任多种高级领导职务，涉及梦百合领域。他是西北大学范伯格医学院的著名临床医生和前神经外科教授，也是西北大学神经外科住院医师项目主任。Ondra博士于2012年离开临床实践服务于政府，并被总统巴拉克·奥巴马任命为美国退伍军人事务部健康事务高级政策顾问。他也曾任职于白宫的总统执行办公室。在白宫，他曾担任多个职位，包括国家科学和技术委员会卫生信息技术联合主席，联邦卫生信息技术政策和标准委员会成员，平价医疗法案实施副小组成员。2012年离开政府后，翁德拉博士回到西北纪念医院担任高级副总裁和首席医疗官。2013年，他转投Health Care Service Corporation“；HCSC”；，该公司是美国最大的客户所有的健康保险公司，在伊利诺斯州、蒙大拿州、新墨西哥州、俄克拉荷马州和德克萨斯州以Blue Cross和Blue Shield的名义运营，并担任其公司高级副总裁和首席医疗官。Ondra博士目前担任伊利诺伊卫斯理大学（Illinois Wesleyan University）的受托人，并担任Electrocore，Inc.（一家公开上市的生物电子医药公司）的董事会董事。他是几家私人公司的高级顾问，包括Altrazeal、Amida Technology Solutions、Cygnus-AI、Mountain Lake Health、Physiq和Westexec Advisors。他还曾在TriWest梦百合联盟、Louis B.Sullivan梦百合转化研究所的董事会任职，并担任国防部国防脊髓/脊柱损伤和脊柱爆炸损伤科学咨询委员会主席。
Stephen L. Ondra is currently the Chief Executive Officer of North Star Healthcare Consulting, LLC, which he founded in 2017. Prior to that, he served in a variety of senior leadership roles that spanned the healthcare space. A renowned clinician and former Professor of Neurosurgery at Northwestern’s Feinberg School of Medicine and the Residency Program Director for neurosurgery at Northwestern. Dr. Ondra left clinical practice in 2012 to serve in government and was appointed by President Barack Obama as the Senior Policy Advisor for Health Affairs at the U.S. Department of Veterans Affairs. He also served at the White House in the Executive Office of the President. At the White House, he served in several positions, including co-chair of the National Science and Technology Council for Health Information Technology, member of the Federal Health Information Technology Policy and Standards Committees, and member of the Implementation Deputy Group for the Affordable Care Act. After leaving government in 2012 Dr. Ondra returned to Northwestern Memorial Hospital as Senior Vice President and Chief Medical Officer. In 2013 he moved to Health Care Service Corporation “HCSC”, the largest customer-owned health insurance company in the United States, which operates as Blue Cross and Blue Shield in Illinois, Montana, New Mexico, Oklahoma and Texas, and served as its corporate Senior Vice President and Chief Medical Officer. Dr. Ondra currently serves as a Trustee of Illinois Wesleyan University and as a director on the board of directors of ElectroCore, Inc., a publicly traded bioelectronic medicine company. He is a senior advisor to several private companies including Altrazeal, Amida Technology Solutions, Cygnus-AI, Mountain Lake Health, physIQ and WestExec Advisors. He has also served on the board of TriWest Healthcare Alliance, the Louis B. Sullivan Institute for Healthcare Transformation, and chaired the scientific advisory boards for the Defense Spinal Cord/Column Injury and the Spine Blast Injury for the Department of Defense. - StephenL.Ondra目前是North Star梦百合Consulting，LLC的首席执行官，该公司由他于2017年创立。此前，他曾担任多种高级领导职务，涉及梦百合领域。他是西北大学范伯格医学院的著名临床医生和前神经外科教授，也是西北大学神经外科住院医师项目主任。Ondra博士于2012年离开临床实践服务于政府，并被总统巴拉克·奥巴马任命为美国退伍军人事务部健康事务高级政策顾问。他也曾任职于白宫的总统执行办公室。在白宫，他曾担任多个职位，包括国家科学和技术委员会卫生信息技术联合主席，联邦卫生信息技术政策和标准委员会成员，平价医疗法案实施副小组成员。2012年离开政府后，翁德拉博士回到西北纪念医院担任高级副总裁和首席医疗官。2013年，他转投Health Care Service Corporation“；HCSC”；，该公司是美国最大的客户所有的健康保险公司，在伊利诺斯州、蒙大拿州、新墨西哥州、俄克拉荷马州和德克萨斯州以Blue Cross和Blue Shield的名义运营，并担任其公司高级副总裁和首席医疗官。Ondra博士目前担任伊利诺伊卫斯理大学（Illinois Wesleyan University）的受托人，并担任Electrocore，Inc.（一家公开上市的生物电子医药公司）的董事会董事。他是几家私人公司的高级顾问，包括Altrazeal、Amida Technology Solutions、Cygnus-AI、Mountain Lake Health、Physiq和Westexec Advisors。他还曾在TriWest梦百合联盟、Louis B.Sullivan梦百合转化研究所的董事会任职，并担任国防部国防脊髓/脊柱损伤和脊柱爆炸损伤科学咨询委员会主席。
- Stephen L. Ondra is currently the Chief Executive Officer of North Star Healthcare Consulting, LLC, which he founded in 2017. Prior to that, he served in a variety of senior leadership roles that spanned the healthcare space. A renowned clinician and former Professor of Neurosurgery at Northwestern’s Feinberg School of Medicine and the Residency Program Director for neurosurgery at Northwestern. Dr. Ondra left clinical practice in 2012 to serve in government and was appointed by President Barack Obama as the Senior Policy Advisor for Health Affairs at the U.S. Department of Veterans Affairs. He also served at the White House in the Executive Office of the President. At the White House, he served in several positions, including co-chair of the National Science and Technology Council for Health Information Technology, member of the Federal Health Information Technology Policy and Standards Committees, and member of the Implementation Deputy Group for the Affordable Care Act. After leaving government in 2012 Dr. Ondra returned to Northwestern Memorial Hospital as Senior Vice President and Chief Medical Officer. In 2013 he moved to Health Care Service Corporation “HCSC”, the largest customer-owned health insurance company in the United States, which operates as Blue Cross and Blue Shield in Illinois, Montana, New Mexico, Oklahoma and Texas, and served as its corporate Senior Vice President and Chief Medical Officer. Dr. Ondra currently serves as a Trustee of Illinois Wesleyan University and as a director on the board of directors of ElectroCore, Inc., a publicly traded bioelectronic medicine company. He is a senior advisor to several private companies including Altrazeal, Amida Technology Solutions, Cygnus-AI, Mountain Lake Health, physIQ and WestExec Advisors. He has also served on the board of TriWest Healthcare Alliance, the Louis B. Sullivan Institute for Healthcare Transformation, and chaired the scientific advisory boards for the Defense Spinal Cord/Column Injury and the Spine Blast Injury for the Department of Defense.
- Gail B. Marcus
-
Gail B.Marcus是霍夫斯特拉大学（Hofstra University）卫生专业系助理教授。此前，她曾担任马萨诸塞州药学和健康科学学院2016-2019年梦百合业务和行政服务助理教授兼助理院长。在获得学术任命之前，Marcus博士在诊断，药房福利管理，咨询和管理式护理方面担任过各种高级领导职务，包括Calloway Labs的首席执行官2013-2015年Caris Diagnostics的首席执行官（2006-2008年）以及Exceptional Leaders International的梦百合咨询实践的顾问和实践领导者（2015-2017年）。Marcus博士曾在多家财富100强公司担任领导职务，包括联合梦百合和信诺梦百合。她任职于Natera，Inc.（NTRA）（全球基因检测和诊断公司）和Engineering World Health（非营利组织）的董事会。Marcus博士于2019年完成了她在Medicare中心和Medicaid Services临床诊断实验室测试咨询小组的任期。Marcus博士是NACD董事会领导研究员。
Gail B. Marcus is an Assistant Professor of the Department of Health Professions at Hofstra University. Previously, she served as Assistant Professor and Assistant Dean of the Healthcare Business and Administrative Services at the Massachusetts College of Pharmacy and Health Sciences 2016-2019. Prior to her academic appointments, Dr. Marcus held a variety of senior leadership roles in diagnostics, pharmacy benefit management, consulting and managed care, including CEO of Calloway Labs 2013-2015 CEO of Caris Diagnostics (2006-2008), and consultant and practice leader in the healthcare consulting practice of Exceptional Leaders International (2015-2017). Dr. Marcus held leadership roles at several Fortune 100 companies, including United Healthcare and CIGNA Healthcare. She serves on the Board of Natera, Inc. (NTRA), a global genetic testing and diagnostics company, and Engineering World Health, a non-profit organization. In 2019 Dr. Marcus completed her tenure on the Centers for Medicare & Medicaid Services Advisory Panel on Clinical Diagnostic Laboratory Tests. Dr. Marcus is an NACD Board Leadership Fellow. - Gail B.Marcus是霍夫斯特拉大学（Hofstra University）卫生专业系助理教授。此前，她曾担任马萨诸塞州药学和健康科学学院2016-2019年梦百合业务和行政服务助理教授兼助理院长。在获得学术任命之前，Marcus博士在诊断，药房福利管理，咨询和管理式护理方面担任过各种高级领导职务，包括Calloway Labs的首席执行官2013-2015年Caris Diagnostics的首席执行官（2006-2008年）以及Exceptional Leaders International的梦百合咨询实践的顾问和实践领导者（2015-2017年）。Marcus博士曾在多家财富100强公司担任领导职务，包括联合梦百合和信诺梦百合。她任职于Natera，Inc.（NTRA）（全球基因检测和诊断公司）和Engineering World Health（非营利组织）的董事会。Marcus博士于2019年完成了她在Medicare中心和Medicaid Services临床诊断实验室测试咨询小组的任期。Marcus博士是NACD董事会领导研究员。
- Gail B. Marcus is an Assistant Professor of the Department of Health Professions at Hofstra University. Previously, she served as Assistant Professor and Assistant Dean of the Healthcare Business and Administrative Services at the Massachusetts College of Pharmacy and Health Sciences 2016-2019. Prior to her academic appointments, Dr. Marcus held a variety of senior leadership roles in diagnostics, pharmacy benefit management, consulting and managed care, including CEO of Calloway Labs 2013-2015 CEO of Caris Diagnostics (2006-2008), and consultant and practice leader in the healthcare consulting practice of Exceptional Leaders International (2015-2017). Dr. Marcus held leadership roles at several Fortune 100 companies, including United Healthcare and CIGNA Healthcare. She serves on the Board of Natera, Inc. (NTRA), a global genetic testing and diagnostics company, and Engineering World Health, a non-profit organization. In 2019 Dr. Marcus completed her tenure on the Centers for Medicare & Medicaid Services Advisory Panel on Clinical Diagnostic Laboratory Tests. Dr. Marcus is an NACD Board Leadership Fellow.
- Luis A. Clavell Rodriguez
-
Luis A. Clavell Rodriguez， San Jorge Children's Hospital的首席医疗官兼总裁。他是儿童肿瘤学组（the Children's Oncology Group）及the Dana Farber Acute Lymphoblastic Leukemia Consortium的主要调查者。他是NACD的董事会领导成员。他从1980年至1994年任University of Puerto Rico医学院的小儿科和病理学的教授；从1984年至1994年任小儿科肿瘤学的主任。他在临床调查领域有着专业的技能。他是董事会的执行委员会主席，投资和财政委员会成员。
Luis A. Clavell Rodriguez served as chief executive officer of the Comprehensive Cancer Center of the University of Puerto Rico from 2015 until his retirement in 2020. As part of the services provided by San Jorge Children’s Medical Specialties PSC, a professional services corporation that employs Dr. Clavell-Rodríguez, he served as chief medical officer at San Jorge Children’s Hospital from 1994 to 2019. During that period, he also served as president of the Professional Board at San Jorge Children’s Hospital. He is the principal investigator for the Children’s Oncology Group, a clinical trial organization, and co-PI in the Puerto Rico National Cancer Institute Oncology Community Research Program, organizations sponsored by the National Cancer Institute. He also serves as member of the Board of Managers of SHC Holding, LLC and SHC Owner, LLC, Companys affiliates currently developing a healthcare facility. Dr. Clavell is also a professor of pediatrics and cancer medicine at the University of Puerto Rico’s School of Medicine. He has particular expertise in translational research, and health delivery research and policy. During his tenure at the Comprehensive Cancer Center he had the primarily responsibility for its hospital’s successful construction, accreditation and operation. He is a NACD Board Leadership Fellow. - Luis A. Clavell Rodriguez， San Jorge Children's Hospital的首席医疗官兼总裁。他是儿童肿瘤学组（the Children's Oncology Group）及the Dana Farber Acute Lymphoblastic Leukemia Consortium的主要调查者。他是NACD的董事会领导成员。他从1980年至1994年任University of Puerto Rico医学院的小儿科和病理学的教授；从1984年至1994年任小儿科肿瘤学的主任。他在临床调查领域有着专业的技能。他是董事会的执行委员会主席，投资和财政委员会成员。
- Luis A. Clavell Rodriguez served as chief executive officer of the Comprehensive Cancer Center of the University of Puerto Rico from 2015 until his retirement in 2020. As part of the services provided by San Jorge Children’s Medical Specialties PSC, a professional services corporation that employs Dr. Clavell-Rodríguez, he served as chief medical officer at San Jorge Children’s Hospital from 1994 to 2019. During that period, he also served as president of the Professional Board at San Jorge Children’s Hospital. He is the principal investigator for the Children’s Oncology Group, a clinical trial organization, and co-PI in the Puerto Rico National Cancer Institute Oncology Community Research Program, organizations sponsored by the National Cancer Institute. He also serves as member of the Board of Managers of SHC Holding, LLC and SHC Owner, LLC, Companys affiliates currently developing a healthcare facility. Dr. Clavell is also a professor of pediatrics and cancer medicine at the University of Puerto Rico’s School of Medicine. He has particular expertise in translational research, and health delivery research and policy. During his tenure at the Comprehensive Cancer Center he had the primarily responsibility for its hospital’s successful construction, accreditation and operation. He is a NACD Board Leadership Fellow.
- Manuel Figueroa Collazo
-
Manuel Figueroa Collazo，自1999年起任一家教育软件开发公司VERNET有限公司的总裁。他在担任高级管理职务获得了超过25年经验，在计算机、信心及电子通信产业的所有管理水平上取得了超过25年的工作经验。他是 Lucent Technologies的首席执行官，也是 AT&T Bell Laboratories的一个部门负责人。他是NACD董事会的领导成员。他是薪酬委员会和人才发展委员会的主席，企业治理和提名委员会及执行委员会成员。
Manuel Figueroa Collazo is the president of Smart Networks, LLC, a telecommunications, hosting and data processing company in Puerto Rico, and of MFC Investments, Inc. From 1999 to 2019 he was president of Vernet, Inc., an educational software development company. He was previously CEO of AT&T de Mexico and currently chairs the State Committee for NSF’s Established Program to Stimulate Competitive Research EPSCoR in Puerto Rico. He is a NACD Board Leadership Fellow and a certified Cyber Security Oversight Professional. - Manuel Figueroa Collazo，自1999年起任一家教育软件开发公司VERNET有限公司的总裁。他在担任高级管理职务获得了超过25年经验，在计算机、信心及电子通信产业的所有管理水平上取得了超过25年的工作经验。他是 Lucent Technologies的首席执行官，也是 AT&T Bell Laboratories的一个部门负责人。他是NACD董事会的领导成员。他是薪酬委员会和人才发展委员会的主席，企业治理和提名委员会及执行委员会成员。
- Manuel Figueroa Collazo is the president of Smart Networks, LLC, a telecommunications, hosting and data processing company in Puerto Rico, and of MFC Investments, Inc. From 1999 to 2019 he was president of Vernet, Inc., an educational software development company. He was previously CEO of AT&T de Mexico and currently chairs the State Committee for NSF’s Established Program to Stimulate Competitive Research EPSCoR in Puerto Rico. He is a NACD Board Leadership Fellow and a certified Cyber Security Oversight Professional.
- Roberto Garcia Rodriguez
-
Roberto Garcia Rodriguez，自2013年12月起任首席运营官；自2010年5月起任秘书；从2008年5月至2013年12月任副总裁兼总法律顾问。
Roberto Garcia Rodriguez has served as the Company’s president and chief executive officer since January 2016. He served as the Company’s chief operating officer from December 2013 to December 2015 and as the Company’s vice president and general counsel from May 2008 to December 2013. Mr. García-Rodríguez serves on the BCBSA board of directors and is a NACD Board Leadership Fellow. - Roberto Garcia Rodriguez，自2013年12月起任首席运营官；自2010年5月起任秘书；从2008年5月至2013年12月任副总裁兼总法律顾问。
- Roberto Garcia Rodriguez has served as the Company’s president and chief executive officer since January 2016. He served as the Company’s chief operating officer from December 2013 to December 2015 and as the Company’s vice president and general counsel from May 2008 to December 2013. Mr. García-Rodríguez serves on the BCBSA board of directors and is a NACD Board Leadership Fellow.
- Cari M. Dominguez
-
Cari M. Dominguez，自2007年起任一家全球劳动力供应商Manpower Group公司的董事，且是执行委员会和人力资源委员会成员。她从2001年至2006年任美国平等雇佣机会委员会（ the U.S. Equal Employment Opportunity Commission）的主席。她是一家管理咨询公司Dominguez & Associates的总裁；该公司由她在1999年创立。她自2013年起任NACD的董事会成员，且是NACD董事会的领导成员。1995年至1998年，她是一家国际行政研究公司Heidrick & Struggles的合伙人。1993年至1995年，她是一家咨询公司Spencer Stuart的董事。1989年至1993年，她是the Employment Standards Administration的助理秘书，以及美国劳工局 Federal Contract Compliance Programs办公室主任。在那之前，她担任美国银行的高级管理职务。她是企业治理和提名委员会及薪酬和人才反战委员会成员。
Cari M. Dominguez is president of Dominguez & Associates, a management consulting firm, since 2007. Prior to that, Ms. Dominguez held several leadership positions in the public and private sectors, including chair of the United States Equal Employment Opportunity Commission from 2001 to 2006 Partner of Heidrick & Struggles, a consulting firm, from 1995 to 1998 Director of Spencer Stuart, a consulting firm, from 1993 to 1995 and Assistant Secretary for Employment Standards Administration, and Director of the Office of Federal Contract Compliance Programs of the U.S. Department of Labor, from 1989 to 1993. She has also held a series of executive positions, including SVP and Chief Talent Officer at Loma Linda University Health, and with Bank of America from 1984 to 1989. Ms. Dominguez serves as a director of ManpowerGroup, Inc., a global workforce solutions provider, since 2007 and is a member of its compensation and human resources committee. She also serves as a trustee of The Calvert Funds since 2008 and as a director, faculty member, and Board Leadership Fellow of the NACD. - Cari M. Dominguez，自2007年起任一家全球劳动力供应商Manpower Group公司的董事，且是执行委员会和人力资源委员会成员。她从2001年至2006年任美国平等雇佣机会委员会（ the U.S. Equal Employment Opportunity Commission）的主席。她是一家管理咨询公司Dominguez & Associates的总裁；该公司由她在1999年创立。她自2013年起任NACD的董事会成员，且是NACD董事会的领导成员。1995年至1998年，她是一家国际行政研究公司Heidrick & Struggles的合伙人。1993年至1995年，她是一家咨询公司Spencer Stuart的董事。1989年至1993年，她是the Employment Standards Administration的助理秘书，以及美国劳工局 Federal Contract Compliance Programs办公室主任。在那之前，她担任美国银行的高级管理职务。她是企业治理和提名委员会及薪酬和人才反战委员会成员。
- Cari M. Dominguez is president of Dominguez & Associates, a management consulting firm, since 2007. Prior to that, Ms. Dominguez held several leadership positions in the public and private sectors, including chair of the United States Equal Employment Opportunity Commission from 2001 to 2006 Partner of Heidrick & Struggles, a consulting firm, from 1995 to 1998 Director of Spencer Stuart, a consulting firm, from 1993 to 1995 and Assistant Secretary for Employment Standards Administration, and Director of the Office of Federal Contract Compliance Programs of the U.S. Department of Labor, from 1989 to 1993. She has also held a series of executive positions, including SVP and Chief Talent Officer at Loma Linda University Health, and with Bank of America from 1984 to 1989. Ms. Dominguez serves as a director of ManpowerGroup, Inc., a global workforce solutions provider, since 2007 and is a member of its compensation and human resources committee. She also serves as a trustee of The Calvert Funds since 2008 and as a director, faculty member, and Board Leadership Fellow of the NACD.
- David H. Chafey, Jr.
-
David H. Chafey, Jr.，自2013年1月起任Puerto Rico的政府发展银行（the Government Development Bank）的董事会主席。2009年至2010年，他一家公开交易的金融控股公司Popular有限公司的总裁兼首席运营官；2004年至2010年任Popular的一家子公司Banco Popular de Puerto Rico的总裁。1996年至2009年，他担任过许多高级行政职务，包括Popular的执行副总裁。他在几家公司董事会任职，包括 Popular公司、 VISA Latin （美国和加勒比）及 VISA International。他是审计委员会及投资和财政委员会成员。
David H. Chafey, Jr. was a member of the administrative board of the Puerto Rico Dairy Industry Development Fund and director of Industria Lechera de Puerto Rico, Inc. Indulac from July 2016 to June 2019. Mr. Chafey was also the chair of the board of directors of the Government Development Bank for Puerto Rico from January 2013 to June 2015. Previously, he served as president and chief operating officer of Popular, Inc., a publicly traded financial holding company, from 2009 to 2010 and president of Banco Popular de Puerto Rico, a subsidiary of Popular, Inc., from 2004 to 2010. He also served in various senior executive positions within Popular, Inc., including chief financial officer and executive vice president. Mr. Chafey also served in several boards of directors, including Popular, Inc., VISA Latin America and Caribbean, and VISA International. He is a NACD Board Leadership Fellow. - David H. Chafey, Jr.，自2013年1月起任Puerto Rico的政府发展银行（the Government Development Bank）的董事会主席。2009年至2010年，他一家公开交易的金融控股公司Popular有限公司的总裁兼首席运营官；2004年至2010年任Popular的一家子公司Banco Popular de Puerto Rico的总裁。1996年至2009年，他担任过许多高级行政职务，包括Popular的执行副总裁。他在几家公司董事会任职，包括 Popular公司、 VISA Latin （美国和加勒比）及 VISA International。他是审计委员会及投资和财政委员会成员。
- David H. Chafey, Jr. was a member of the administrative board of the Puerto Rico Dairy Industry Development Fund and director of Industria Lechera de Puerto Rico, Inc. Indulac from July 2016 to June 2019. Mr. Chafey was also the chair of the board of directors of the Government Development Bank for Puerto Rico from January 2013 to June 2015. Previously, he served as president and chief operating officer of Popular, Inc., a publicly traded financial holding company, from 2009 to 2010 and president of Banco Popular de Puerto Rico, a subsidiary of Popular, Inc., from 2004 to 2010. He also served in various senior executive positions within Popular, Inc., including chief financial officer and executive vice president. Mr. Chafey also served in several boards of directors, including Popular, Inc., VISA Latin America and Caribbean, and VISA International. He is a NACD Board Leadership Fellow.
- Joseph A. Frick
-
Joseph A. Frick， 2013年10月，他加入董事会，担任补偿委员会成员；1993年，他加入Independence Blue Cross，担任多个职务，包括人力资源部高级副总裁，直到2005年，他成为总裁和首席行政官；2010年，他以Independence Blue Cross总裁和首席行政官职位退休，但继续担任董事会副主席、战略计划委员会总裁以及行政委员会成员；在加入Independence Blue Cross之前，他是Philadelphia Newspapers人力资源部副总裁。在他职业生涯早期，他在Westinghouse Electric Corporation工作，担任运营管理和人力资源部多项职务。除了他在Independence Blue Cross继续工作外，他还是Diversified Search的副主席和管理合伙人。他是拉刹大学、 Colon Cancer Alliance以及 Triple-S Management Corporation董事会成员。他获有美国圣母大学文科学士学位以及圣徒学院工商管理硕士学位。
Joseph A. Frick is currently a senior advisor to Diversified Search, a national executive search firm. From May 2011 to October 2016 he served as executive vice chair of the firm. He is also vice-chair of the board of directors, member of the executive committee, and chair of the strategic initiatives committee of Independence Blue Cross, a health insurance company. He previously served as president and chief executive officer of Independence Blue Cross from 2005 to 2010 and as senior vice president of human resources and administration from 1993 to 2005. He was a member of the board of directors and chair of the Compensation and Talent Development Committee of BioTelemetry, Inc., a publicly-traded company, since October 2013 until February 2021 when the transaction whereby BioTelemetry was acquired by Royal Phillips closed, at which time it's board was dissolved. Before serving in Independence Blue Cross, he worked in various management positions within the publishing and the electronics industries. He also served on the boards of directors of BCBSA and America's Health Insurance Plans, among others. Mr. Frick also serves on the Philadelphia regional advisory board of the PNC Bank. As a colon cancer survivor, Mr. Frick is a member of the CEO's Against Cancer of the American Cancer Society. He is a NACD Board Leadership Fellow. - Joseph A. Frick， 2013年10月，他加入董事会，担任补偿委员会成员；1993年，他加入Independence Blue Cross，担任多个职务，包括人力资源部高级副总裁，直到2005年，他成为总裁和首席行政官；2010年，他以Independence Blue Cross总裁和首席行政官职位退休，但继续担任董事会副主席、战略计划委员会总裁以及行政委员会成员；在加入Independence Blue Cross之前，他是Philadelphia Newspapers人力资源部副总裁。在他职业生涯早期，他在Westinghouse Electric Corporation工作，担任运营管理和人力资源部多项职务。除了他在Independence Blue Cross继续工作外，他还是Diversified Search的副主席和管理合伙人。他是拉刹大学、 Colon Cancer Alliance以及 Triple-S Management Corporation董事会成员。他获有美国圣母大学文科学士学位以及圣徒学院工商管理硕士学位。
- Joseph A. Frick is currently a senior advisor to Diversified Search, a national executive search firm. From May 2011 to October 2016 he served as executive vice chair of the firm. He is also vice-chair of the board of directors, member of the executive committee, and chair of the strategic initiatives committee of Independence Blue Cross, a health insurance company. He previously served as president and chief executive officer of Independence Blue Cross from 2005 to 2010 and as senior vice president of human resources and administration from 1993 to 2005. He was a member of the board of directors and chair of the Compensation and Talent Development Committee of BioTelemetry, Inc., a publicly-traded company, since October 2013 until February 2021 when the transaction whereby BioTelemetry was acquired by Royal Phillips closed, at which time it's board was dissolved. Before serving in Independence Blue Cross, he worked in various management positions within the publishing and the electronics industries. He also served on the boards of directors of BCBSA and America's Health Insurance Plans, among others. Mr. Frick also serves on the Philadelphia regional advisory board of the PNC Bank. As a colon cancer survivor, Mr. Frick is a member of the CEO's Against Cancer of the American Cancer Society. He is a NACD Board Leadership Fellow.
高管简历
中英对照 | 中文 | 英文- Madeline Hernandez Urquiza
Madeline Hernandez Urquiza，Triple-S Advantage, Inc.总裁。自2015年1月起担任Triple-S Advantage, Inc.（公司的Medicare Advantage子公司）总裁；2014年到2015年担任Triple-S Advantage, Inc.代理总裁；2012年到2014年担任Triple-S Salud, Inc.首席风险官；2010年到2012年担任Triple-S Salud, Inc.风险管理副总裁。
Madeline Hernandez Urquiza has been our Executive Vice President and Chief Operating Officer since August 2017 and the President of our managed care subsidiaries Triple-S Salud, Inc. and Triple-S Advantage, Inc., since January 2016 and January 2015 respectively. She rejoined our Company in 2010 and assumed various positions in Triple-S Salud, Inc., including Vice President of Risk Management and Chief Risk Officer before assuming her current roles.- Madeline Hernandez Urquiza，Triple-S Advantage, Inc.总裁。自2015年1月起担任Triple-S Advantage, Inc.（公司的Medicare Advantage子公司）总裁；2014年到2015年担任Triple-S Advantage, Inc.代理总裁；2012年到2014年担任Triple-S Salud, Inc.首席风险官；2010年到2012年担任Triple-S Salud, Inc.风险管理副总裁。
- Madeline Hernandez Urquiza has been our Executive Vice President and Chief Operating Officer since August 2017 and the President of our managed care subsidiaries Triple-S Salud, Inc. and Triple-S Advantage, Inc., since January 2016 and January 2015 respectively. She rejoined our Company in 2010 and assumed various positions in Triple-S Salud, Inc., including Vice President of Risk Management and Chief Risk Officer before assuming her current roles.
- Jose. Novoa Loyola
什么事？Novoa Loyola于2015年7月加入我公司并担任该职位。此前，他曾于2002年至2015年任职波多黎各和加勒比心血管中心（the Cardiovascular Center of Puerto Rico and Caribbean），担任多种职务，包括医学董事、心脏病部门主管和制药和治疗委员会成员。
Jose. Novoa Loyola joined our company and assumed his position in July 2015. Previously, he served at the Cardiovascular Center of Puerto Rico and the Caribbean from 2002 to 2015 in various positions, including Medical Director, Chief of the Cardiology Department and member of the Pharmacy and Therapeutics Committee.- 什么事？Novoa Loyola于2015年7月加入我公司并担任该职位。此前，他曾于2002年至2015年任职波多黎各和加勒比心血管中心（the Cardiovascular Center of Puerto Rico and Caribbean），担任多种职务，包括医学董事、心脏病部门主管和制药和治疗委员会成员。
- Jose. Novoa Loyola joined our company and assumed his position in July 2015. Previously, he served at the Cardiovascular Center of Puerto Rico and the Caribbean from 2002 to 2015 in various positions, including Medical Director, Chief of the Cardiology Department and member of the Pharmacy and Therapeutics Committee.
- Jose M. Del Amo Mojica
Jose M.del Amo Mojica于2017年3月被任命为Triple-S Propiedad，Inc.的总裁。此前，他曾于2014年至2017年2月担任Triple-S Propiedad，Inc.的承销和索赔高级副总裁。
Jose M. Del Amo Mojica was appointed President of Triple-S Propiedad, Inc. in March 2017. Previously, he served as Senior Vice President of Underwriting and Claims of Triple-S Propiedad, Inc. from 2014 to February 2017.- Jose M.del Amo Mojica于2017年3月被任命为Triple-S Propiedad，Inc.的总裁。此前，他曾于2014年至2017年2月担任Triple-S Propiedad，Inc.的承销和索赔高级副总裁。
- Jose M. Del Amo Mojica was appointed President of Triple-S Propiedad, Inc. in March 2017. Previously, he served as Senior Vice President of Underwriting and Claims of Triple-S Propiedad, Inc. from 2014 to February 2017.
- Ilia S. Rodriguez Torres
Ilia S.Rodriguez Torres于2018年5月加入我们公司并担任职务。加入公司之前，她于2017年至2018年担任跨国饮料公司Beliv的人力资源总监，该公司在中美洲，加勒比和南美洲开展业务，生物制药公司Ferring Pharmaceuticals，Inc.的区域高级人力资源总监，2015年至2017年，多乐银行控股公司Doral Financial Corporation人力资源执行Vice President，2013年至2015年。
Ilia S. Rodriguez Torres joined our Company and assumed her position in May 2018. Before joining the Company, she served as Human Resources Director of Beliv, a multinational beverages company with operations in Central America, the Caribbean and South America, from 2017 to 2018 Regional Senior Human Resources Director of Ferring Pharmaceuticals, Inc., a biopharmaceutical company, from 2015 to 2017 and Executive Vice President of Corporate Human Resources at Doral Financial Corporation, holding company of Doral Bank, from 2013 to 2015.- Ilia S.Rodriguez Torres于2018年5月加入我们公司并担任职务。加入公司之前，她于2017年至2018年担任跨国饮料公司Beliv的人力资源总监，该公司在中美洲，加勒比和南美洲开展业务，生物制药公司Ferring Pharmaceuticals，Inc.的区域高级人力资源总监，2015年至2017年，多乐银行控股公司Doral Financial Corporation人力资源执行Vice President，2013年至2015年。
- Ilia S. Rodriguez Torres joined our Company and assumed her position in May 2018. Before joining the Company, she served as Human Resources Director of Beliv, a multinational beverages company with operations in Central America, the Caribbean and South America, from 2017 to 2018 Regional Senior Human Resources Director of Ferring Pharmaceuticals, Inc., a biopharmaceutical company, from 2015 to 2017 and Executive Vice President of Corporate Human Resources at Doral Financial Corporation, holding company of Doral Bank, from 2013 to 2015.
- Ivelisse M. Fernandez Cruz
Ivelisse M.Fernandez Cruz于2018年5月加入我们公司并担任职务。2012年至2018年，她担任波多黎各梦百合相关服务提供商MMM Holdings，LLC的首席行政官。
Ivelisse M. Fernandez Cruz joined our Company and assumed her position in May 2018. From 2012 to 2018 she served as Chief Administrative Officer of MMM Holdings, LLC, a provider of healthcare related services in Puerto Rico.- Ivelisse M.Fernandez Cruz于2018年5月加入我们公司并担任职务。2012年至2018年，她担任波多黎各梦百合相关服务提供商MMM Holdings，LLC的首席行政官。
- Ivelisse M. Fernandez Cruz joined our Company and assumed her position in May 2018. From 2012 to 2018 she served as Chief Administrative Officer of MMM Holdings, LLC, a provider of healthcare related services in Puerto Rico.
- Pedro Aponte Gil De Lamadrid
Pedro Aponte Gil de Lamadrid于2019年12月被任命为首席信息官。此前，他曾担任该公司的代理首席信息官兼明星、质量和业务创新Vice President。他也是Abartys Health公司（健康分析公司）的顾问委员会成员。
Pedro Aponte Gil De Lamadrid was appointed Chief Information Officer in December 2019. Previously he served as Acting Chief Information Officer and Vice President of STARS, Quality and Business Innovation at the Company. He is also member of the Board of Advisors of Abartys Health, a health analytics company.- Pedro Aponte Gil de Lamadrid于2019年12月被任命为首席信息官。此前，他曾担任该公司的代理首席信息官兼明星、质量和业务创新Vice President。他也是Abartys Health公司（健康分析公司）的顾问委员会成员。
- Pedro Aponte Gil De Lamadrid was appointed Chief Information Officer in December 2019. Previously he served as Acting Chief Information Officer and Vice President of STARS, Quality and Business Innovation at the Company. He is also member of the Board of Advisors of Abartys Health, a health analytics company.
- Juan R. Serrano
Juan R.Serrano加入我们公司，并于2020年7月任职。从2018年到2020年，他曾担任Palliative Care Newco，Inc.（早期风险投资，专注于高风险，高成本和弱势人群的人口健康管理）的董事会成员。2015年至2017年，他曾担任Munich Health North America，Inc.（美国健康再保险公司）的总裁兼首席执行官。Serrano之前曾担任Catholic Health Initiatives（一家美国医院公司）Payer Strategy高级副总裁。
Juan R. Serrano joined our Company and assumed his position in July 2020. From 2018 to 2020 he served on the Board of Palliative Care NewCo, Inc., an early-stage venture focused on population health management for high-risk, high-cost and vulnerable populations. From 2015 to 2017 he was President and Chief Executive Officer of Munich Health North America, Inc., a U.S health reinsurer. Mr. Serrano previously served as SVP of Payer Strategy for Catholic Health Initiatives, a U.S. hospital company.- Juan R.Serrano加入我们公司，并于2020年7月任职。从2018年到2020年，他曾担任Palliative Care Newco，Inc.（早期风险投资，专注于高风险，高成本和弱势人群的人口健康管理）的董事会成员。2015年至2017年，他曾担任Munich Health North America，Inc.（美国健康再保险公司）的总裁兼首席执行官。Serrano之前曾担任Catholic Health Initiatives（一家美国医院公司）Payer Strategy高级副总裁。
- Juan R. Serrano joined our Company and assumed his position in July 2020. From 2018 to 2020 he served on the Board of Palliative Care NewCo, Inc., an early-stage venture focused on population health management for high-risk, high-cost and vulnerable populations. From 2015 to 2017 he was President and Chief Executive Officer of Munich Health North America, Inc., a U.S health reinsurer. Mr. Serrano previously served as SVP of Payer Strategy for Catholic Health Initiatives, a U.S. hospital company.
- Arturo Carrion Crespo
Arturo Carrion Crespo，自1998年起任我公司人寿保险子公司 Triple-S Vida有限公司的总裁。
Arturo Carrion Crespo is the President of Triple-S Vida, Inc., our life insurance subsidiary, since 1998.- Arturo Carrion Crespo，自1998年起任我公司人寿保险子公司 Triple-S Vida有限公司的总裁。
- Arturo Carrion Crespo is the President of Triple-S Vida, Inc., our life insurance subsidiary, since 1998.
- Juan J. Roman Jimenez
Juan J. Roman Jimenez从2002年开始担任财务部副总裁兼首席财务官。
Juan J. Roman Jimenez rejoined our Company and assumed his current position in January 2016. Previously, he served as Executive Vice President and Chief Financial Officer of EVERTEC, INC., a full-service transaction processing company in Latin America and a NYSE listed company, from April 2012 to August 2015 and as Executive Vice President and Chief Financial Officer of EVERTEC Group, LLC from 2011 to 2012.- Juan J. Roman Jimenez从2002年开始担任财务部副总裁兼首席财务官。
- Juan J. Roman Jimenez rejoined our Company and assumed his current position in January 2016. Previously, he served as Executive Vice President and Chief Financial Officer of EVERTEC, INC., a full-service transaction processing company in Latin America and a NYSE listed company, from April 2012 to August 2015 and as Executive Vice President and Chief Financial Officer of EVERTEC Group, LLC from 2011 to 2012.
- Roberto Garcia Rodriguez
Roberto Garcia Rodriguez，自2013年12月起任首席运营官；自2010年5月起任秘书；从2008年5月至2013年12月任副总裁兼总法律顾问。
Roberto Garcia Rodriguez has served as the Company’s president and chief executive officer since January 2016. He served as the Company’s chief operating officer from December 2013 to December 2015 and as the Company’s vice president and general counsel from May 2008 to December 2013. Mr. García-Rodríguez serves on the BCBSA board of directors and is a NACD Board Leadership Fellow.- Roberto Garcia Rodriguez，自2013年12月起任首席运营官；自2010年5月起任秘书；从2008年5月至2013年12月任副总裁兼总法律顾问。
- Roberto Garcia Rodriguez has served as the Company’s president and chief executive officer since January 2016. He served as the Company’s chief operating officer from December 2013 to December 2015 and as the Company’s vice president and general counsel from May 2008 to December 2013. Mr. García-Rodríguez serves on the BCBSA board of directors and is a NACD Board Leadership Fellow.
- Carlos L. Rodriguez Ramos
Carlos L. Rodriguez Ramos，自2013年12月起任代理总法律顾问；从2013年2月至2013年12月任Triple-S Management Corporation助理总法律顾问；从2011年至2012年任Puerto Rico总督的程序事务的员工副主管；2010年至2011年任Puerto Rico总督的助理法律和立法咨询者；2007年至2009年任Puerto Rico高级法院的法律办事员兼首席审判员。
Carlos L. Rodriguez Ramos joined our Company in 2013 and assumed his current position in January 2016. Mr. Rodríguez-Ramos’ previous positions at the Company include Associate General Counsel, Acting General Counsel and Assistant Secretary. Before joining our Company, he served as Adjunct Professor at the School of Law of the University of Puerto Rico from 2010 to 2014 and as Deputy Chief of Staff of Programmatic Affairs for the Governor of Puerto Rico from 2011 to 2012.- Carlos L. Rodriguez Ramos，自2013年12月起任代理总法律顾问；从2013年2月至2013年12月任Triple-S Management Corporation助理总法律顾问；从2011年至2012年任Puerto Rico总督的程序事务的员工副主管；2010年至2011年任Puerto Rico总督的助理法律和立法咨询者；2007年至2009年任Puerto Rico高级法院的法律办事员兼首席审判员。
- Carlos L. Rodriguez Ramos joined our Company in 2013 and assumed his current position in January 2016. Mr. Rodríguez-Ramos’ previous positions at the Company include Associate General Counsel, Acting General Counsel and Assistant Secretary. Before joining our Company, he served as Adjunct Professor at the School of Law of the University of Puerto Rico from 2010 to 2014 and as Deputy Chief of Staff of Programmatic Affairs for the Governor of Puerto Rico from 2011 to 2012.